Pillstats
Rx only · Tablet · Oral

Pindolol

Pindolol

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US17 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC07AA03
RxCUI (US)8332
US makers7 labelers
Packages17
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.215$0.431$0.646$0.862Dec 2025Mar 2026Jul 2026
$0.749
Latest avg · Jul 22, 2026
+3%
Since Dec 17, 2025
6
Active US suppliers
47%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5991.2K1.8K2.4K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.6K
Rx · 2026 Q1
127K
Units dispensed
-22%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
PD-Rx Pharmaceuticals, Inc.unknown4SUPPLYING
Bryant Ranch Prepackrepackager3SUPPLYING
Marlex Pharmaceuticals Incunknown2SUPPLYING
Unichem Pharmaceuticals (USA), Inc.unknown2SUPPLYING
Westminster Pharmaceuticals, LLCunknown2SUPPLYING
ANI Pharmaceuticals, Inc.unknown2SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown2EXITED 2027

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 30, 2026
    RESOLVEDShortage resolved: Pindolol Tablet (Sun Pharmaceutical Industries, Inc.)

    Pindolol Tablet — reported in shortage by Sun Pharmaceutical Industries, Inc.. Therapeutic category: Cardiovascular.

  • Jan 30, 2026
    SHORTAGEDrug shortage: Pindolol Tablet (Sun Pharmaceutical Industries, Inc.)

    Pindolol Tablet — reported in shortage by Sun Pharmaceutical Industries, Inc.. Therapeutic category: Cardiovascular.